The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

remonmedical.com

Stage

Acquired | Acquired

Total Raised

$10M

About Remon Medical Technologies

Remon Medical Technologies develops and commercializes smart, miniature implants which enable physicians to assess and treat a variety of medical conditions in a non-invasive manner. Remon's platform has broad applications for patient management, post-operative monitoring, nerve and tissue stimulation, local drug delivery, and drug development.

Remon Medical Technologies Headquarter Location

Caesarea,

Israel

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Remon Medical Technologies Patents

Remon Medical Technologies has filed 23 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/14/2006

8/27/2019

Sensors, Congenital heart defects, Implants (medicine), Cardiac anatomy, Cardiology

Grant

Application Date

11/14/2006

Grant Date

8/27/2019

Title

Related Topics

Sensors, Congenital heart defects, Implants (medicine), Cardiac anatomy, Cardiology

Status

Grant

Latest Remon Medical Technologies News

Bioacoustics Sensing Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2027 | AT T Inc., Avisoft Bioacoustics, Honeywell International Inc., Matsushita Electric Industrial, Med-Acoustics, Inc., MSI Transducers Corporation, Pacesetter, Panasonic Corporation, Remon Medical Technologies, Samsung Electronics Co., Ltd.

Feb 17, 2021

| AT T Inc., Avisoft Bioacoustics, Honeywell International Inc., Matsushita Electric Industrial, Med-Acoustics, Inc., MSI Transducers Corporation, Pacesetter, Panasonic Corporation, Remon Medical Technologies, Samsung Electronics Co., Ltd. The report analyzes factors affecting bioacoustics sensing market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period. By SMN Bureau The proposed Bioacoustics Sensing Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics. The Bioacoustics Sensing Market sample report includes an exclusive analysis of COVID-19 pandemic on the market space under scrutiny. The sample represents the format of the overall study which is designed to provide clarity on the structure of the report and some data points demonstrated in an attempt to provide insights into the study quality. >>>Get Sample PDF Copy: Bioacoustics sensing technology is getting popularity in numerous fields, primarily in wearable consumer electronics and healthcare. Bioacoustics sensing technology is capable to potentially convert the user interface with consumer electronics such as mobile phones and others to be projection to augment environments. In the healthcare sector, this technology supports in determining body sounds on skin surface, blood pressure and pulse, observing respiration, and assessment of muscle strength for enhancing stamina, among the other such healthcare applications. The key players profiled in this Bioacoustics Sensing Market study includes: 1. AT T Inc. 10. Samsung Electronics Co., Ltd. The driving factor for bioacoustics sensing market is the sensible growth of artificial intelligence and its significant acceptance. There are several products and solutions of bioacoustics sensing technology in the market, which are based on artificial intelligence such as connected devices and wearable devices. Moreover, the usage of bioacoustics sensing technology within consumer electronic area for creating lighter, and better material, is also expected to support the growth of bioacoustics sensing market aggressively. This research report will give you deep insights about the Bioacoustics Sensing Market and it will also help you in strategic decision making. The final research document is an exhaustive document comprising of 150 pages. All our reports are usually purchased across industries by Executives, Managers, Senior Managers, Strategy people, Directors, Vice Presidents, CXOs, etc. and help them in understanding about the market trends and analysis, competition, industry landscape, market size, market revenue, forecast, COVID-19 impact analysis, SWOT analysis, etc. A thoroughgoing evaluation of the Bioacoustics Sensing market restrains included in the report which represents the difference to drivers of the market and gives scope for strategic insights and developments. The research study has amalgamated the growth analysis of different aspects that enhance the Bioacoustics Sensing market growth scenario. It constitutes key market drivers, restraints and trends that transform the market in either a positive or negative manner. Purchase a Copy of this research report @ The "Global Bioacoustics Sensing Market Analysis to 2027" is a specialized and in-depth study of the bioacoustics sensing industry with a special focus on the global market trend analysis. The report aims to provide an overview of bioacoustics sensing market with detailed market segmentation by component, application, and geography. The global bioacoustics sensing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading bioacoustics sensing market players and offers key trends and opportunities in the market. Additionally, in case you are interested in other topic at the moment, please share your exact requirements with us as apart from our off-the-shelf reports, we also provide customized reports that are prepared keeping in view the clients precise requirements. To let you know, on an annual basis, we publish over 450+ report across 18 distinct industry verticals. ABOUT US: The Insight Partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact US: North America: +1 646 491 9876 Asia-Pacific: +91 20 6727 8686

You May Also Like

E
Erydel

EryDel develops a red-blood-cell-based drug delivery device for the treatment of rare neurodegenerative diseases. Its proprietary technology relies upon the encapsulation of drugs into red cells taken from the patient's own blood, which are then re-infused into the patient.

N
Next Breath

Next Breath, LLC is a contract pharmaceutical research and development organization dedicated to pre-clinical identification and evaluation of commercially viable respiratory and nasal drug delivery platforms. NB's business will discover and exploit optimal drug and delivery device combinations that will increase the company's partners' probability of success when their products advance into human clinical trials and the marketplace. Next Breath seeks to meet the pharmaceutical industry's outsourcing needs and to provide intellectual expertise to biotechnology companies that are developing inhalation products.

A
AerovectRx

AerovectRx is an aerosol therapeutic company providing effective and dosage-controlled drug delivery using the respiratory system as the gateway for better health. Products under development by AerovectRx are designed to deliver a wide variety of therapies through multiple-use mass immunization as well as personal-use nebulizers. Potential targeted therapeutic candidates for the AerovectRx technology include treatments for asthma, cystic fibrosis, pulmonary hypertension, chronic obstructive pulmonary disease (COPD), diabetes, pain management, and for delivery of vaccines and anti-viral drugs.

K
Kucera Pharmaceutical Company

Kucera Pharmaceutical Company is based in Winston-Salem, NC. The company started with a drug delivery approach that combined or conjugated delivery molecules with therapeutic molecules as a platform technology, both to improve the properties of the attached therapeutic molecules (making them orally available and improving distribution) and to extend patent life.

O
Optotrack

Optotrack, Inc. is a high-tech company leading in the research and development of optical, imaging, chemical, as well as biological sensors and microsystems. The company is dedicated to commercializing its intellectual properties based on microfabrication and nanotechnology to seize rapidly growing market opportunities in the industries of healthcare, communication, and homeland security. Optotrack, Inc. offers a broad range of technology and business solutions from design through production to marketing and sales. The company combine decades of industry experience and R&D expertise in thin-film science, polymer engineering, solid-state sensing, digital imaging, optoelectronics, RF circuitry, medical diagnostics, microfluidics, and drug delivery to provide enabling technologies to the company's partners, customers, and community. The firm aims to deliver products and services of exceptional quality to cast the future, to improve the life quality for everyone.

B
Brainsgate

BrainsGate develops a technology for modulation of cerebro-vascular properties through neuro-stimulation of the spheno-palatine ganglion. Affected properties are central to many CNS disorders - blood vessel permeability and blood flow. Currently targeted applications include treatment of ischemic stroke and drug delivery to the CNS through modifying the permeability of the blood brain barrier. The Company has initiated clinical trials, delivering a chemotherapeutic agent to primary brain tumor patients.)

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.